No-reflow- Mechanism, Diagnosis and Treatment for patients with STEMI.pdf

1、No-reflow phenomenon in patients with ST-elevated myocardial infarction is associated with high mortality and morbidity. Indeed it has been noted the incidence of this phenomenon varies from 5％ to 50% in the set up of pr

2、imary percutaneous coronary interventions and the outcome in the long run is poor. Multiple mechanism have been put forward to explain this phenomenon but without really revealing its secret. Several diagnostic methods s

3、uch as angiography, myocardial contrast echography, intravascular ultrasound among others, have helped study the changes that occurrence of no-reflow during primary percutaneous coronary interventions. The treatment are

4、also limited to reperfusion and prevention of embolisation while it is associated with a high long term mortality rate and other cardiac conditions such as malignant arrhythmias, cardiac failure and sudden death. As such